SCHEMBL9594480

SCHEMBL9594480

CSc1nc(N)nc2c1ncn2C(OCCCOC(=O)C(C)C)OC(=O)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HK1 P19367 1/20 0.43
▸ HKDC1 Q2TB90 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.38
▸ HDAC1 Q13547 2/20 0.37
▸ HDAC2 Q92769 2/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ CDK1 P06493 3/20 0.36
▸ CDK2 P24941 3/20 0.36
▸ CCNB1 P14635 2/20 0.36
▸ CCNE1 P24864 2/20 0.36
▸ CYP2C19 P33261 2/20 0.35
▸ SLC29A1 Q99808 4/20 0.35
▸ CDC20 Q12834 1/20 0.34
▸ PRKACA P17612 1/20 0.33
▸ CCNA2 P20248 1/20 0.33
▸ PRKACG P22612 1/20 0.33
▸ PRKACB P22694 1/20 0.33
▸ MAPK3 P27361 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CCNA1 P78396 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10814393 0.83 HK1 (0.39) HK1HKDC1TDP1HDAC1HDAC2
SCHEMBL9584502 0.80 CDK1 (0.49) HDAC1HDAC2HDAC8CDK1CDK2
SCHEMBL9584895 0.80 HK1 (0.41) HK1HKDC1TDP1HDAC1HDAC2
SCHEMBL9583879 0.79 ADORA2A (0.48) ALDH1A1LMNACYP1A2CYP3A4HIF1A
SCHEMBL9583290 0.76 CDK5 (0.42) TDP1CDK1CDK2CCNB1CCNE1
SCHEMBL9583170 0.75 CDK1 (0.47) HDAC1HDAC2HDAC8CDK1CDK2
SCHEMBL9584563 0.74 HDAC6 (0.41) HDAC1HDAC2HDAC8CDK1CDK2
SCHEMBL9583319 0.74 HK1 (0.41) HK1HKDC1TDP1HDAC1HDAC2
SCHEMBL9584007 0.73 HDAC1 (0.36) HDAC1HDAC2HDAC8CDK1CDK2
SCHEMBL9583081 0.73 CDK1 (0.44) HDAC1HDAC2HDAC8CDK1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250535-A Herpes virus; nontoxic; side effect reduction; humans and veterinary medicine SYNTEX INC. (US) 1993-10-05 — — US disclosed
US-4803271-A Process for preparing guanine derivatives SYNTEX (U.S.A.) INC. (US) 1989-02-07 — — US disclosed
EP-0085424-A2 Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1983-08-10 — — EP disclosed
Send feedback